The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease

HK Kim, US Tantry, SC Smith Jr… - Thrombosis and …, 2021 - thieme-connect.com
East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during
antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor …

[HTML][HTML] Effects of social media and mobile health apps on pregnancy care: meta-analysis

KL Chan, M Chen - JMIR mHealth and uHealth, 2019 - mhealth.jmir.org
Background The use of social media and mobile health (mHealth) apps has been increasing
in pregnancy care. However, the effectiveness of these interventions is still unclear …

[HTML][HTML] Cardiovascular research using the Korean national health information database

EK Choi - Korean circulation journal, 2020 - synapse.koreamed.org
Abstract The Korean National Health Information Database (NHID) contains nationwide
claims data, including sociodemographic data, health care utilization, health screening data …

Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion

DG Della Rocca, M Magnocavallo, L Di Biase… - Cardiovascular …, 2021 - jacc.org
Objectives This study evaluated the long-term efficacy of a standard antithrombotic strategy
versus half-dose direct oral anticoagulation (DOAC) after Watchman implantation …

Effectiveness and safety of four direct oral anticoagulants in Asian patients with nonvalvular atrial fibrillation

YH Chan, HF Lee, LC See, HT Tu, TF Chao, YH Yeh… - Chest, 2019 - Elsevier
Background Whether four direct oral anticoagulants (DOACs) are superior to warfarin in
Asian patients with nonvalvular atrial fibrillation (NVAF) remains unclear. Methods This …

Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events

J Tamargo, JC Kaski, T Kimura… - European Heart …, 2022 - academic.oup.com
Awareness of racial/ethnic disparities represents a key challenge for healthcare systems that
attempt to provide effective healthcare and to reduce existing inequalities in the use of and …

Comparative effectiveness and safety of direct oral anticoagulants and warfarin in patients with atrial fibrillation and chronic liver disease: a nationwide cohort study

OD Lawal, HD Aronow, F Shobayo, AL Hume… - Circulation, 2023 - Am Heart Assoc
Background: The benefit-risk profile of direct oral anticoagulants (DOACs) compared with
warfarin, and between DOACs in patients with atrial fibrillation (AF) and chronic liver disease …

[HTML][HTML] Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

GF Romiti, B Corica, M Proietti, DA Mei… - …, 2023 - thelancet.com
Background Previous studies suggested potential ethnic differences in the management and
outcomes of atrial fibrillation (AF). We aim to analyse oral anticoagulant (OAC) prescription …

Use of proton pump inhibitors vs histamine 2 receptor antagonists for the risk of gastric cancer: population-based cohort study

GY Shin, JM Park, J Hong, YK Cho… - Official journal of the …, 2021 - journals.lww.com
METHODS: A population-based cohort study using the Korean National Health Insurance
Services Database. The participants with first prescription of PPIs and H 2 RA with normal …

Long-term clinical outcomes of underdosed direct oral anticoagulants in patients with atrial fibrillation and atrial flutter

H Ashraf, P Agasthi, A Shanbhag, RA Mehta… - The American Journal of …, 2021 - Elsevier
Background Although direct oral anticoagulants (DOACs) have been shown to be effective
at reducing the risk of stroke in patients with atrial fibrillation/flutter (AF), they are sometimes …